[144] Clear Secure, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 summary for Clear Secure, Inc. (YOU): Notice of proposed sale of 40,000 Class A Common shares through J.P. Morgan Securities LLC (390 Madison Avenue, New York). The aggregate market value is $1,280,000 as stated in the filing; shares outstanding are listed as 92,266,338. Approximate sale date: 08/05/2025.

Acquisition details: shares were acquired on 09/01/2019 as a Pre IPO investment from the issuer and paid in cash. The filing reports no securities sold in the past 3 months and includes the standard signer representation regarding undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Planned sale of 40,000 Class A shares (aggregate value $1.28M) appears routine and is unlikely to materially change capitalization.

The Form 144 discloses a proposed sale of 40,000 Class A Common shares through J.P. Morgan Securities LLC with an aggregate market value reported at $1,280,000 and an approximate sale date of 08/05/2025. The filing states the shares were acquired 09/01/2019 as a pre-IPO investment and paid in cash. The filer reports Nothing to Report for sales in the past three months. From a market-impact perspective, the document provides transparent transaction details but no indicators of material liquidity pressure or forced disposition.

Corporate Governance Expert

TL;DR: Filing meets Rule 144 disclosure elements; includes fields for 10b5-1 plan date though none is populated in the provided content.

The Form 144 contains required issuer and transaction information, broker identification (J.P. Morgan Securities LLC), acquisition origin (Pre IPO investment from the issuer on 09/01/2019), and the signature/attestation language regarding material nonpublic information. The form includes a field for the date of plan adoption or instruction if relying on Rule 10b5-1, but no plan date is shown in the supplied content. The disclosure is consistent with routine insider liquidity reporting and compliance with Rule 144 procedural items.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	J.P. Morgan Securities LLC 390 Madison Avenue 6th Floor New York NY 10017	40000	1280000	92266338	08/05/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	09/01/2019	Pre IPO investment	Issuer			40000	09/01/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Clear Secure (YOU) Form 144 propose?

The filing proposes sale of 40,000 Class A Common shares via J.P. Morgan Securities LLC, aggregate market value $1,280,000, approximate sale date 08/05/2025.

When and how were the shares acquired?

The shares were acquired on 09/01/2019 as a Pre IPO investment from the issuer and the payment was in cash.

Has the filer sold any Clear Secure securities in the past three months?

The Form 144 states Nothing to Report for securities sold during the past three months.

Which broker is named to execute the sale?

The broker listed is J.P. Morgan Securities LLC at 390 Madison Avenue, 6th Floor, New York, NY 10017.

How many shares outstanding does the filing report?

The filing lists 92,266,338 shares outstanding.

Does the filing indicate a Rule 10b5-1 trading plan adoption date?

The form includes a field for the date of plan adoption or instruction under Rule 10b5-1, but no adoption date is provided in the supplied content.